全球脐带血银行市场规模（按银行类型、应用程式、最终用户、地区、范围和预测）

脐带血库市场的规模及预测

脐带血库市场规模预计在 2023 年达到 20.5 亿美元，到 2031 年将达到 66.7 亿美元，2024 年至 2031 年的复合年增长率为 14%。脐带血库是收集脐带血、提取干细胞和其他免疫系统细胞并冷冻保存以备将来医疗使用的过程。出生后残留在脐带和胎盘的血液称为脐带血。母胎细胞移植是在足月或接近足月时进行的，以增强母亲和婴儿的免疫系统，为出生做准备。

脐带血含有大量干细胞，可治疗80多种遗传疾病。这些疾病包括癌症、血液疾病、糖尿病和免疫系统疾病，都可以用脐带血干细胞治疗。

由于治疗应用的进步、新兴市场的尚未开发的机会以及提高认识的努力，全球脐带血银行市场预计将扩大。

全球脐带血银行市场动态

影响全球脐带血银行市场的关键市场动态

主要市场驱动因子

提高正念：

准父母逐渐意识到脐带血库的好处，例如其能够治疗各种疾病和问题，对脐带血库的兴趣也日益增加。

临床测试的进展：

临床研究的不断进步，特别是在再生医学和基础微生物治疗领域，正在扩大脐带血未分化生物的预期应用，从而增加人们对脐带血库的兴趣。

进展性疾病增加：

白血病、淋巴瘤和遗传性疾病等慢性病的发生率不断上升，促使先进疗法，尤其是基因疗法的应用激增，以支持脐带血疗效领域的持续研究和开发。因此，对脐带血益处的认识和研究支持的提高促进了各个地区采用脐带血库。

政府推动与支持：

政府支持未分化细胞测试和移植的举措和指导方针以及公共脐带血捐赠中心的建立，正在透过提高脐带血银行市场的关注度和可用性来帮助该市场的发展。

机械式进步：

脐带血处理、储存和移植程序的创新进步正在提高脐带血未分化生物的合理性和生存能力，使脐带血库成为父母和医疗保健提供者更具吸引力的选择。

扩大医疗消费：

医疗保健利用率的提高和对医疗保健基础设施日益增长的兴趣（尤其是在新兴经济体中）正在推动脐带血库的接受度并支持其发展。

主要问题：

有限的正念：

儘管脐带血银行有许多好处，但准父母对脐带血和组织保存重要性的认识仍然有限。人们正在越来越多地认识到脐带血的潜在修復用途。

大笔开支：

管理脐带血库的成本可能非常高，包括初始处理和储存费用以及持续的维护费用。脐带血库的高昂费用可能会阻止一些家庭考虑它作为一种选择，特别是在医疗保健对某些人没有保障或限制的地区。

道德问题

脐带血库的商业化引发了道德问题，特别是有关脐带血的使用问题。由于文化的限制，未来几年脐带血库的采用率可能会下降。

管理困难：

在许多国家，脐带血库依赖政府监督，遵守政府要求可能是一项艰鉅的任务。确保脐带血单位的选择、处理、储存和传播方面的指导方针的一致性，对市场提出了深思熟虑和权威的课题。

容量限制：

脐带血库单位的生产能力有限，无法满足每年日益增长的脐带血采集数量。随着容量限制的出现，丢弃的脐带血单位数量将会增加，因此需要对框架开发和技术创新产生兴趣。

主要趋势：

提高认识与接受度：

孕妇越来越意识到脐带血库的好处，包括使用脐带血干细胞治疗各种疾病和病症的可能性。这种日益增长的认识和接受度正在推动全球对脐带血银行服务的需求。

技术进步：

技术的进步，包括干细胞分离、处理和冷冻保存技术的改进，正在提高储存脐带血的品质和活力。这些技术进步使得脐带血库更有效可靠，吸引了更多的客户。

扩大公共脐带血库：

公共脐带血库在提供用于移植和研究目的的脐带血干细胞方面发挥越来越重要的作用。政府和医疗保健组织正在投资扩大公共脐带血库基础设施，以便为有需要的患者提供更多多样化、高品质的脐带血。

目录

第 1 章 全球脐带血银行市场简介

• 市场介绍
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 全球脐带血银行市场展望

• 概述
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球脐带血银行市场（依银行类型划分）

• 概述
• 私部门
• 公开
• 混合

6. 全球脐带血银行市场（依应用）

• 概述
• 血液系统恶性肿瘤
• 非恶性疾病
• 再生医学

7. 全球脐带血银行市场（依最终用户划分）

• 概述
• 医院
• 研究机构
• 其他

8. 全球脐带血银行市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 9 章。

• 概述
• 各公司的市场排名
• 主要发展策略

第十章 公司简介

• Lifeforce Cryobanks
• China Cord Blood Corporation
• Cordlife Group
• Virgin Health Bank
• Cord Blood America
• CBR Systems
• Cryo-Cell International
• ViaCord
• National Cord Blood Program
• Americord

第 11 章 重大进展

• 产品发布/开发
• 合併和收购
• 业务扩展
• 伙伴关係和合作关係

第 12 章附录

• 相关研究

Cord Blood Banking Market Size And Forecast

Cord Blood Banking Market size is valued at USD 2.05 Billion in 2023 and is projected to reach USD 6.67 Billion by 2031, growing at a CAGR of 14% from 2024 to 2031. Cord blood banking is the process of taking cord blood, extracting its stem cells and other immune system cells, and cryogenically storing them for future medical use. The blood that stays in the umbilical cord and placenta after birth is known as cord blood (short for umbilical cord blood). A maternal-fetal cell transfer occurs at or near term to enhance the immune systems of both the mother and the baby in preparation for childbirth.

Cord blood includes a large number of stem cells that can be used to cure over 80 hereditary illnesses. These illnesses include cancer, blood illnesses, diabetes, and immunological diseases, all of which can be treated with cord blood stem cells.

The Global Cord Blood Banking Market is expected to rise due to advancements in therapeutic application, untapped opportunities in developing regions, and initiatives to spread awareness.

Global Cord Blood Banking Market Dynamics

The key market dynamics that are shaping the global Cord Blood Banking Market include:

Key Market Drivers:

Increasing Mindfulness:

Developing mindfulness among eager guardians about the advantages of cord blood banking, for example, its capability to treat different sicknesses and problems, is driving interest for cord blood banking administrations.

Progressions in Clinical Exploration:

Continuous headways in clinical examination, especially in regenerative medication and foundational microorganism treatment, are extending the expected uses of line blood undifferentiated organisms, consequently driving the interest for cord blood banking.

Rising Commonness of Ongoing Diseases:

The rising predominance of persistent sicknesses like leukemia, lymphoma, and hereditary issues is surging the application of advanced treatments, especially genetic-based therapies, to support the ongoing research and development in the field of effectiveness of cord bloods. Thus, the growing awareness regarding the benefits of cord blood and supporting research are driving the adoption of cord blood banking across diverse regions.

Government Drives and Backing:

Government drives and guidelines supporting undifferentiated cell examination and transplantation, alongside the foundation of public cord blood donation centers, are helping the development of the Cord Blood Banking Market by advancing mindfulness and availability.

Mechanical Progressions:

Innovative headways in cord blood handling, stockpiling, and transplantation procedures have worked on the reasonability and viability of line blood undifferentiated organisms, making cord blood banking a more alluring choice for guardians and medical services suppliers.

Expanding Medical Care Consumption:

Rising medical care use and interests in medical care foundation, especially in arising economies, are driving the reception of cord blood banking administrations and supporting the progression of this business.

Key Challenges:

Restricted Mindfulness:

Despite the likely advantages of cord blood banking, there is as yet restricted mindfulness among hopeful guardians about the significance of cord blood and tissue protection. Growing awareness about its potential restorative applications stays a test.

Significant Expense:

Cord blood banking administrations can be exorbitant, including introductory handling and stockpiling charges along with progressing upkeep charges. The significant expense of string blood banking might dissuade a few families from considering it as a choice, especially in districts where medical care costs are not covered by protection or are restrictive for some.

Moral Worries:

There are moral contemplations surrounding the commercialization of cord blood banking, especially the ethical issues concerning the use of cord blood. The cultural restrictions are likely to decrease its adoption in the coming years.

Administrative Difficulties:

Cord blood banking is dependent upon administrative oversight in numerous nations, and consistence with administrative necessities can be mind boggling and tedious. Guaranteeing consistence with guidelines for assortment, handling, stockpiling, and dissemination of cord blood units presents calculated and authoritative difficulties for the market.

Capacity Limits:

The capacity limitations of cord blood banking units is unable to meet the increasing number of cord blood gathered every year. As the capacity constraints emerge, the volume of discarded cord blood units increments, thereby requiring interests in framework development and innovation.

Key Trends:

Increasing Awareness and Acceptance:

There is growing awareness among expectant parents about the benefits of cord blood banking, such as the potential to treat various diseases and conditions using stem cells derived from cord blood. This increased awareness and acceptance are driving demand for cord blood banking services globally.

Technological Advancements:

Advances in technology, including improvements in stem cell isolation, processing, and cryopreservation techniques, are enhancing the quality and viability of stored cord blood units. These technological advancements are making cord blood banking more effective and reliable, thus attracting more customers.

Expansion of Public Cord Blood Banks:

Public cord blood banks are playing an increasingly important role in providing access to cord blood stem cells for transplantation and research purposes. Governments and healthcare organizations are investing in the expansion of public cord blood banking infrastructure to increase the availability of diverse and high-quality cord blood units for patients in need.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cord Blood Banking Market Regional Analysis

Here is a more detailed regional analysis of the global Cord Blood Banking Market:

North America:

North America has a well-established healthcare system and a high degree of knowledge among pregnant parents about the benefits of cord blood banking. As a result, the region has a higher adoption rate of cord blood banking services than other parts of the world, enabling the region dominate the market.

The regulatory frameworks governing cord blood banking in North America are well-established and supportive public and private banks. Regulatory authorities, such as the FDA (Food and Drug Administration) in the United States, establish standards and oversight to ensure cord blood banking techniques are safe and effective.

The region is at the forefront of scientific developments in healthcare, such as stem cell research and biotechnology. This technological skill allows North American cord blood banks to offer state-of-the-art storage and processing facilities, enhancing the quality and viability of stored cord blood units.

Asia Pacific:

Asia Pacific has a huge and quickly growing population, with countries such as China, India, and Southeast Asian nations seeing rise in birth rates. This demographic trend is generating demand for cord blood banking services as more parents learn about the benefits of keeping cord blood for future medical use.

Rising disposable incomes and growing middle-class populations in Asia Pacific countries are driving up spending on healthcare services, especially prenatal and neonatal care. This rising healthcare spending is fueling demand for innovative medical technologies, such as cord blood banking, to protect the health and well-being of newborns and pregnant women.

Healthcare professionals, patient advocacy groups, and educational institutions throughout Asia Pacific are raising awareness about the medicinal potential of cord blood stem cells.

Global Cord Blood Banking Market: Segmentation Analysis

The Global Cord Blood Banking Market is segmented on the basis of Bank Type, Application, End-User, And Geography.

Cord Blood Banking Market, By Bank Type

• Private
• Public
• Hybrid

Based on Bank Type, The market is segmented into Private, Public, and Hybrid. The private cord blood banking segment holds the largest market share, accounting for approximately 80% of the global market revenue. On the other hand, the public cord blood banking segment is expected to grow at a faster rate in the coming years due to increasing government support for public cord blood banking programs and growing awareness of the ethical implications of private cord blood banking.

Cord Blood Banking Market, By Application

• Hematological Malignancies
• Non-Malignant Diseases
• Regenerative Medicine

Based on Application, The market is segmented into Hematological Malignancies, Non-Malignant Diseases, and Regenerative Medicine. The hematological malignancies is expected to dominate the global Cord Blood Banking Market over the forecast timeframe. Growing presence of cancer is surging the need for cord blood banking for effective treatment, thereby enabling this segment retain its top position. While other applications such as non-malignant diseases and regenerative medicine is anticipated to be promising, their widespread adoption in the clinical sector is still in its early stages.

Cord Blood Banking Market, By End-User

• Hospitals
• Research Institutes
• Others

Based on End-User, The market is segmented into Hospitals, Research Institutes, and Others. As per our analyst, hospitals segment is estimated to hold large share in the market. Increasing child birth in hospitals acts a primary point of contact in facilitating cord blood collection. Also, the availability of well-equipped infrastructure and healthcare professionals to safely collect, process, and store cord blood samples for potential future use will help hospitals keep contact with well-known cord blood banking.

Key Players

• The " Global Cord Blood Banking Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
• Lifeforce Cryobanks, China Cord Blood Corporation, Cordlife Group, Virgin Health Bank, Cord Blood America, CBR Systems, Cryo-Cell International, ViaCord, National Cord Blood Program, Americord, StemCyte, Cryo-Save Group, NeoStem, and Blood Centers of America.

Our market analysis includes a section specifically devoted to such major players, where our analysts give an overview of each player's financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned players globally are also included in the competitive landscape section.

• Cord Blood Banking Market Recent Developments
• In May 2021, SingHealth Duke-NUS Academic Medical Centre and Cordlife announced their partnership. This strategy will benefit the company in developing new technologies related to stem cell and blood therapies and increase its share in the industry.
• In August 2019, Cordlife announced its geographical expansion into Bangladesh. This strategy benefited the company to expand its geographical footprint and acquired a larger market share.
• In January 2024, DKMS Chile launched first collection center in Santiago de Chile to enhance stem cell collection as well as transplant capacity in the country and improve access to treatment for patients in need.

TABLE OF CONTENTS

1 INTRODUCTION TO THE GLOBAL CORD BLOOD BANKING MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CORD BLOOD BANKING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CORD BLOOD BANKING MARKET, BY BANK TYPE

• 5.1 Overview
• 5.2 Private
• 5.3 Public
• 5.4 Hybrid

6 GLOBAL CORD BLOOD BANKING MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hematological Malignancies
• 6.3 Non-Malignant Diseases
• 6.4 Regenerative Medicine

7 GLOBAL CORD BLOOD BANKING MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Research Institutes
• 7.4 Others

8 GLOBAL CORD BLOOD BANKING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 The U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 The U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL CORD BLOOD BANKING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Lifeforce Cryobanks
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 China Cord Blood Corporation
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Cordlife Group
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Virgin Health Bank
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Cord Blood America
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 CBR Systems
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Cryo-Cell International
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 ViaCord
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 National Cord Blood Program
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Americord
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research